RxDoctor Payments Data

Jeanette Wendt

Neurology · Tucson, AZNPI 1104811397

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,685 of the $9,424 with a category attached, or 70.9%. EMD Serono, Inc. accounts for 92.5% of it on its own, with 17 other manufacturers making up the rest.

$9,424in general payments, 2019–2025

Across 43 payments — averaging $219.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$9K
  • Novartis$187
  • Acorda Therapeutics, Inc$115
  • Sunovion Pharmaceuticals Inc.$55
  • Sanofi$50
  • UCB, Inc.$49
  • plus $245 from 12 others
$552,084in research payments, 2019–2025

Across 63 payments — averaging $8763.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$174K
  • F. Hoffmann-la Roche AG$142K
  • Alkermes, Inc.$80K
  • Novartis$56K
  • Sanofi US Services Inc.$32K
  • Adamas Pharmaceuticals, Inc.$28K
  • plus $41K from 4 others

What the payments were for

  • Speaking & faculty fees$6,68571%
  • Travel & lodging$1,95221%
  • Food & beverage$7868%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,424 in reported general payments places this provider in the 70th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona

Other neurology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →